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ABSTRACT
The aim of this study was to develop a sensitive and reliable method for the molecular identification of
pathogenic bacteria. A multiplex PCR-based reverse line blot (mPCR ⁄RLB) hybridisation assay was
developed and evaluated for the rapid identification of 24 systemic and respiratory bacterial pathogens in
routine diagnosis. All species-specific probes designed for the RLB hybridised with amplified DNA only
from the corresponding species. Sensitivity limits of the mPCR ⁄RLB assay varied among the 24 target
organisms from 0.05 pg to 0.5 ng of genomic DNA. The sensitivity of the assay was 2 · 102 CFU ⁄mL for
Streptococcus pneumoniae and 6 · 102 CFU ⁄mL for Escherichia coli. The specificity of each probe was tested
against 24 species. There were no cross-reactions among any of the 43 probes. The mPCR ⁄RLB assay
appeared to be a useful alternative tool for the molecular identification of common pathogens.
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INTRODUCTION
Bacteraemia and sepsis are potentially life-threat-
ening conditions in which rapid identification of
the causative agent is essential to guide the most
appropriate antimicrobial therapy [1,2]. Infection
with different agents can cause similar signs and
symptoms that are often indistinguishable clini-
cally [3].
Cultivation of blood in commercially available
blood culture bottles is the reference standard for
detection of bacteraemia, but usually requires
>72 h for final identification of the infecting
bacteria. In addition, blood cultures often remain
negative, especially if use of antimicrobial agents
in the community is widespread. Rapid identi-
fication of the causative agent in cases of septi-
caemia contributes to better patient outcome,
and can also reduce unnecessary use of broad-
spectrum antibiotics, thereby helping to prevent
the emergence of antibiotic resistance. Based on a
well-established multiplex PCR-based reverse
line blot (mPCR ⁄RLB) hybridisation assay pro-
tocol [4], the present study describes the devel-
opment of an assay that allows the simultaneous
identification of up to 24 common, clinically
significant pathogens.
MATERIALS AND METHODS
Bacterial isolates
Representative strains of 24 bacterial species used to develop
the assay, and their sources, are shown in Table 1. Clinical
isolates (n = 100) from the diagnostic laboratory at the Centre
for Infectious Diseases and Microbiology (Institute of Clinical
Pathology and Medical Research (ICPMR), Westmead, New
South Wales, Australia) were used to evaluate the assay. All
clinical isolates were identified according to standard conven-
tional methods.
DNA extraction
Isolates (c. 5 CFU) from horse blood, chocolate or buffered
charcoal yeast extract agar (BCYE) plate cultures, as appro-
priate, were suspended in 100 lL of digestion buffer (10 mM
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Tris-HCl, pH 8.0, Triton X-100 0.45% v ⁄v, Tween-20
0.45% v ⁄v), heated at 100C for 10 min, and then cooled on
ice. After centrifugation at 16 100 g for 1–2 min, 400 lL of
0.5 · TE buffer (1 · TE is 10 mM Tris, 1 mM EDTA, pH 8.0)
was added to each tube. The tubes were re-centrifuged and
5 lL of supernatant was used as the DNA template in
subsequent amplification experiments.
Primer and probe design
Species-specific primers and probes were designed, based on
a well-established strategy [4], to allow simultaneous
amplification in a mPCR. To minimise cross-hybridisation,
species-specific primers and probes (Table S1, see Supple-
mentary material) were identified by comparison of sequen-
ces in GenBank using the Pileup and Pretty programs in
the Multiple Sequence Analysis program group provided
in Biomanager (http://biomanager.angis.org.au/) by the
Australian National Genomic Information Service (ANGIS).
The oligonucleotide sequences were also analysed for possi-
ble self-interactions and hairpin loop structures, but no
significant theoretical interactions were identified. To test
for theoretical specificity, all the oligonucleotides used were
aligned with the sequence databases of the National Center
for Biotechnology Information (NCBI) using the Basic Local
Alignment Search Tool (BLASTn). Primers were labelled at
the 5¢-end with biotin to allow PCR products to be detected
by hybridisation with a streptavidin–peroxidase substrate in
the RLB assay. All probes were labelled at the 5¢-end with an
amine group to facilitate covalent linkage to nylon mem-
branes and to allow membranes to be stripped and reused
repeatedly.
mPCR
The mPCR mixture containing the 22 primer-pairs was as
follows [4]: 5 lL DNA extract, 0.25 lL each forward
(50 pmol ⁄ lL) and reverse (50 pmol ⁄ lL) primer, 1.25 lL
dNTPs mix (2.5 mM each dNTP), 2.5 lL 10 · PCR buffer,
4.5 mM MgCl2 (final concentration), 0.5 U Hotstar Taq
DNA polymerase (Qiagen, Shanghai, China) and water to
25 lL. mPCR was performed in single tubes and comprised
95C for 15 min, followed by 35 cycles of 94C for 30 s,
60C for 30 s and 72C for 1 min, followed by 72C for
10 min.
RLB hybridisation
The RLB hybridisation assay was performed as described
previously [4], except that the streptavidin–peroxidase conju-
gate (Roche Diagnostics, Basel, Switzerland) was diluted
3:5000 in 2 · SSPE (0.18 M NaCl, 10 mM NaH2PO4, 1 mM
EDTA, pH 7.7) with SDS 0.5% w ⁄v, and the time of exposure
to X-ray film (Hyperfilm; Amersham, Piscataway, NJ, USA)
was 10 min. The oligonucleotide probes were tested at several
concentrations, ranging from 0.6 to 3 pmol ⁄ lL, to determine
the optimal concentration of the probes for RLB.
Determination of analytical sensitivity and specificity
For specificity studies, DNA was extracted from reference
strains (Table 1) using a DNA Miniprep Extraction kit (Sigma,
St Louis, MO, USA) according to the manufacturer’s instruc-
tions, and was tested against all primer sets. Serial ten-fold
dilutions of genomic DNA were prepared in distilled water. In
Table 1. Bacterial species and isolates used to develop and evaluate the multiplex PCR-based reverse line blot
(mPCR ⁄RLB) assay, together with the DNA detection limits for each species
Species Strain ID number
DNA concentration
(mg/L)
Detection limit
of mPCR/RLBa
Genome size
(bp)
Genome
copies/mL
Genome
copies/5 lL
No. of clinical
isolates
Staphylococcus aureus ATCC 25923 43 0.5 pg 2 902 619 3.14 · 104 1.57 · 102 9
Staphylococcus epidermidis ATCC 12228 31.5 0.5 pg 2 499 279 3.65 · 104 1.83 · 102 2
Staphylococcus hominis ATCC 27844 22.4 0.5 pg 2 902 619 3.14 · 104 1.57 · 102 3
Staphylococcus haemolyticus ATCC 29970 5.5 0.5 pg 2 685 015 3.40 · 104 1.7 · 102 3
Staphylococcus saprophyticus ATCC 15305 70 5 pg 2 516 575 3.62 · 105 1.81 · 103 1
Streptococcus pneumoniae SSI serotype 14 2.9 0.5 pg 2 046 115 4.46 · 104 2.23 · 102 7
Streptococcus pyogenes ATCC 19615 8.9 0.5 pg 1 852 441 4.92 · 104 2.46 · 102 3
Streptococcus agalactiae ATCC BAA-22 23.4 5 pg 2 160 267 4.22 · 105 2.11 · 103 5
Neisseria meningitidis ATCC 13102 38.5 5 pg 2 194 961 4.16 · 105 2.08 · 103 2
Moraxella catarrhalis Clinical isolateb 64.4 5 pgd 5
Haemophilus influenzae ATCC 10211 9.4 5 pg 1 830 138 4.98 · 105 2.49 · 103 10
H. influenzae type b PHI ⁄UK 82 50 pg 1 830 138 4.98 · 106 2.49 · 104 3
Bordetella pertussis Clinical isolateb 56.9 5 pg 4 086 189 2.23 · 105 1.11 · 103 4
Escherichia coli ATCC 25922 47.5 5 pg 5 498 450 1.66 · 105 8.3 · 102 6
Pseudomonas aeruginosa ATCC 27853 75 50 pg 6 264 404 1.46 · 106 7.3 · 103 5
Klebsiella pneumoniae ATCC 13883 60.5 0.5 pgc 5
Legionella pneumophila ATCC 33152 45 5 pg 3 345 687 2.73 · 105 1.37 · 103 6
Listeria monocytogenes ATCC 19112 11.4 0.05 pg 2 944 528 3.1 · 103 1.55 · 101 2
Enterococcus faecalis ATCC 29212 28.9 50 pg 3 218 031 2.83 · 106 1.42 · 104 3
Acinetobacter spp. ATCC 42627 57.4 5 pg 3 598 621 2.53 · 105 1.27 · 103 2
Bacteroides fragilis ATCC 25285 39.4 50 pg 5 205 140 1.75 · 105 8.75 · 102 1
Mycobacterium tuberculosis ATCC 27254-H37RvDd 42.5 50 pg 4 411 532 2.07 · 106 1.03 · 104 4
Mycoplasma pneumoniae TW183-ATCC VR-2282 Dd 18 0.5 ng 4 345 492 2.1 · 107 1.05 · 105 5
Chlamydia pneumoniae ATCC 15531b 85.1 0.5 ng 1 225 935 7.44 · 107 3.72 · 105 2
ATCC, American Type Culture Collection; SSI, Statens Serum Institute, Denmark; PHI ⁄ UK, Public Health Institute ⁄UK.
aAs determined by dilution series (see text for details).
bClinical isolates were from the Centre for Infectious Diseases and Microbiology (Institute of Clinical Pathology and Medical Research, Westmead, New South Wales,
Australia) and were identified by standard microbiological methods.
cCurrently, there are no published genome sequences for Moraxella catarrhalis and Klebsiella pneumoniae, so calculation of genome equivalents was not possible.
dGenomic DNA prepared previously and stored in our laboratories.
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addition, serial ten-fold dilutions (starting at 105 CFU ⁄mL) of
suspensions of cultures of Escherichia coli ATCC 25922 and
Streptococcus pneumoniae SSI 14 were prepared in physiological
saline. Crude DNA was extracted from 1 mL of these suspen-
sions by heating at 100C for 10 min.
Sequencing and sequence analysis
Sequencing was performed as described previously [5]. All
programs used in the study were provided by BioManager
(ANGIS), including Work Bench for sequence file manage-
ment, BESTFIT for two sequence comparison, PILEUP and
PRETTY in the multiple sequence analysis program groups,
and BLASTn for sequence searches.
RESULTS
Selection of primers and probes
In total, 48 primers 18–26 bp in length were
designed, with melting temperatures (Tm)
of 59.5–79.3C and amplicon sizes in the range
94–371 bp (Table S1). Forty-two different oligonu-
cleotide probes directed against specific bacteria
were designed. In addition, a universal probe
targeting the 16S rRNA gene was used as a
control. To allow optimal hybridisation under
the same conditions, probes were also designed
with specific physical characteristics, i.e., a length
of 17–28 bp and a Tm of 58.6–70.7C. Initial
evaluation experiments revealed that the optimal
probe concentration was 3 pmol ⁄ lL for the
MccopBAp, BpporinAp, HigyrBAp, LpmipSp,
MpS-Sap and MpS-SSp oligoprobes (Table S1),
and 2 pmol ⁄lL for other probes.
Identification of a range of bacteria
All species-specific probes designed for RLB
hybridised only with amplified DNA from the cor-
responding species. Fig. 1 illustrates the hybridi-
sation patterns obtained with 24 reference strains
of bacteria. Detection limits of the mPCR ⁄RLB
assay varied among the 24 target organisms, from
0.05 pg to 0.5 ng of genomic DNA, or c. 15-106
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Fig. 1. Detection of 24 bacterial reference strains using the multiplex PCR-based reverse line blot assay. DNA dilutions
were as follows: Escherichia coli (500 ng - 5 pg), Bacteroides spp. (BS) (500 ng - 50 pg), Pseudomonas aeruginosa (PA) (5 lg -
50 pg). Probes are indicated on the y-axis, and bacteria are indicated on the x-axis. Numbers refer to reference strains of the
following species: 1, Staphylococcus aureus; 2, Staphylococcus epidermidis; 3, Staphylococcus haemolyticus; 4, Staphylococcus
hominis; 5, Staphylococcus saprophyticus; 6, Enterococcus faecalis; 7, Streptococcus pneumoniae; 8, Streptococcus pyogenes; 9,
Streptococcus agalactiae; 10, Listeria monocytogenes; 11, Moraxella catarrhalis; 12, Neisseria meningitidis; 13, Bordetella pertussis;
14, Haemophilus influenzae; 15, H. influenzae type b; 16, Klebsiella pneumonia; 17, Legionella pneumophila; 18, E. coli; 19,
P. aeruginosa; 20, Mycobacterium tuberculosis; 21, Acinetobacter spp.; 22, Bacteroides spp.; 23, Mycoplasma pneumoniae; and
24, Chlamydia pneumonia.
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genome equivalents in 5 lL (Table 1). The sensi-
tivity of the assay was 2 · 102 CFU ⁄mL for
S. pneumoniae and 6 · 102 CFU ⁄mL for E. coli
(Fig. 1).
When 100 clinical isolates were tested using
the mPCR ⁄RLB assay, the original identities of
all the clinical isolates were confirmed by RLB
with distinct and unambiguous hybridisation
patterns. There were no cross-reactions
among any of the 43 probes, each of which
hybridised only with the corresponding species
among the 24 reference strains and 100 clinical
strains.
Sequence analysis results
Fifteen Haemophilus influenzae isolates, including
four isolates of H. influenzae type b, produced
strong hybridisation signals with the species-
specific forward probe. However, amplification
products from seven isolates produced weak
hybridisation signals, and two isolates produced
a negative hybridisation signal with the reverse
probe. Sequence analysis showed that weak sig-
nals were associated with a single base mutation
and negative results with two base mutations.
A newly identified gyrB sequence with base
mutations was deposited in GenBank with acces-
sion number U32738.
DISCUSSION
The most widely used method for the identifi-
cation of common bacterial infections involves
conventional microbiological culture [6]. Blood
culture is the standard reference method for
detection of bacteraemia, but requires incubation
for 8–24 h, and for up to 72 h for final identifi-
cation [6]. If antimicrobial therapy has already
been started, blood cultures are likely to be
negative, even in cases of severe sepsis. In China,
98% of children with common colds and other
upper respiratory infections are given antimicro-
bial agents [7]. For the clinician, rapid identifi-
cation of the causative agent in blood cultures or
body fluids contributes to a better outcome. In
addition, unnecessary use of broad-spectrum
antibiotics and the risk of emergence of antibiotic
resistance are reduced because the identity of the
agent provides clues to its susceptibility.
Although molecular identification techniques,
e.g., PCR, have been developed, especially for
slow-growing or fastidious bacteria, it is only
practical to perform a limited number of indi-
vidual PCR assays [8]. A molecular diagnostic
tool that allows rapid simultaneous identification
of many possible aetiological agents is needed to
enable appropriate measures to be instituted
more rapidly and to reduce morbidity and
mortality, especially in children and immuno-
compromised patients.
In order to achieve rapid identification of the
causative agents of bacteraemia and pneumonia,
the present study describes a novel, sensitive
and simple mPCR ⁄RLB assay, based on the use
of primers and probes that recognise conserved
species-specific sequences of bacterial genes
encoding essential molecules [4]. The use of this
mPCR ⁄RLB assay facilitates the identification of
multiple aetiological agents more easily than
either multiple, individual species-specific PCRs
or a PCR using a ‘universal’ bacterial target
followed by sequencing [9]. The probes used in
the present study were 17–28 bp in length and
targeted the 5¢-ends of the amplicons obtained
by PCR. Previous studies have described the use
of a ‘universal’ eubacterial 16S rDNA PCR to
amplify DNA fragments of 360–380 bp, depend-
ing on the bacterial species, at the 5¢-end of the
16S rRNA gene, followed by sequencing or
restriction enzyme analysis to identify the spe-
cies [9]. However, the 16S rDNA region flanked
by these eubacterial primers cannot differentiate
reliably among all relevant eubacterial species
[10]. Therefore, the present study targeted indi-
vidual species-specific genes for amplification,
while corresponding species-specific probes were
used in the mPCR ⁄RLB assay to differentiate
among amplicons from different species and to
increase the specificity. All 100 clinical isolates
tested gave the expected results within c. 7 h of
completion of the mPCR. However, although
there were no cross-reactions among the probes
used for identification of individual species,
there were several species for which the results
were discrepant between the forward and
reverse probes, e.g., H. influenzae, Mycoplasma
pneumoniae and Legionella pneumophila. For the
H. influenzae probes (20–24 bp), the 5¢-end of the
region amplified using the primers designed by
Roth et al. [11] was targeted. In some cases, the
reverse probes gave weak or negative signals
because of minor variations in the target
sequence. However, all isolates were identified
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reliably by the forward probes. It is assumed that
there was a similar explanation for discrepancies
between the two probes for other individual
bacterial species that gave weak or false-negative
signals.
Analysis of amplicons in the RLB chemilumi-
nescent hybridisation assay is 100-fold more
sensitive and faster than the use of ethidium
bromide-stained agarose gels [9], and allows
detection of PCR products not visualised by
fluorescent dye staining [12]. Although the
development of mPCR ⁄RLB assays, which
requires expertise in the design of primers and
probes [4], is relatively expensive and limited to
research or specialised diagnostic laboratories,
the marginal cost of each test, once developed,
is modest, and assays could be produced as
kits for use in the routine diagnostic laboratory.
A particular advantage of mPCR ⁄RLB is that the
membranes can also be stripped and re-used up
to 20 times without substantial loss of sensitivity
[13].
Molecular methods do not depend on the
presence of viable or growing bacteria, and so
are particularly suited to species that cannot be
cultured readily by routine methods, or that
have been damaged by exposure to antibiotics
[6], as has been demonstrated previously by the
use of broad-range PCR amplification directly
with clinical specimens [14]. Further evaluation
of the mPCR ⁄RLB method is warranted with
respect to the direct detection of bacterial DNA
in clinical samples, e.g., cerebrospinal fluid
specimens, that meet cytological and biochemical
criteria for infection despite a negative culture
result.
Finally, the mPCR ⁄RLB method is potentially
suitable for use with large numbers of speci-
mens, as it can analyse 43 clinical samples
simultaneously, does not require expensive
instrumentation, and provides rapid results
when compared with conventional culture and
alternative molecular methods (e.g., sequencing
and restriction fragment length polymorphism
analysis). Thus, this method could become a
powerful and reliable tool for the identification
of common pathogens [4]. Future research
should focus on the direct identification of
bacterial DNA in samples that are suspected on
clinical evidence to contain pathogens, with
particular reference to samples that yield nega-
tive culture results.
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